Omicron, the new covid-19 variant, is spreading worldwide at a very high pace, making it highly fatal. Also, there are some other changes observed in the omicron each day, making it hard to track by the scientist and health care professionals.
Omicron Estimation Is Getting Difficult According To CDC
Omicron is coming up with new characteristics every day, and these changes are evident from the researches happening on the virus constantly. These unique and different characteristics processed in the virus make it very difficult for the CDS to check the estimation of the cases affected by the virus.
Identifying and estimating the omicron cases is turning out to be a very difficult task to accomplish. But regardless of all, it is very important, especially for those infected with the covid-19, because further treatment for the individuals can be decided accordingly.
Any treatment given without accurate information about the variant the individual is affected by can be life-threatening or maybe the reason for severe pain and trouble for the individual in the health prospects. To date, there are basically three different monoclinic antibody treatments done for curing the people affected by the virus in the United States.
Among which two are for the covid-19 delta variants, whereas the one is for the omicron treatment in patients. The difficulty in estimation of the variants can lead to stopping the use of the other two covid-19 monoclonal antibodies treatments so that people can be prevented from omicron.
The estimation of variants in the individual affected can be identified by the gene sequencing method, which is not that easy to be conducted in every individual who gets affected with the virus. It’s a long process with lots of effort to find the accurate variant individual is affected by and know if it is a delta variant of coronavirus or omicron.
Gene sequencing is a specific process that helps the health professionals to know the exact variant the individual is affected by and treat the person accordingly depending on the best monoclinic antibody treatment suited for the condition of the person.
The omicron presence in the United States is estimated to be 53% this week, which is a huge drop according to CDS than the previous week’s estimation, which was 73%.
To this, David O’Connor, who is a virologist at the University of Wisconsin-Madison, stated, “The 73% got a lot more attention than the confidence intervals [which measure the range of certainty on an estimate], and I think this is one example among many where scientists are trying to project an air of confidence about what’s going to happen.”
He explained that genetic sequencing is the only method for accurate results; he gave the example of the game Name that Tune, where one has to guess the name by recognizing the tune, similarly is the case with the virus. It is difficult to guess the song with just the first note similarly by just sparse information omicron identification, and treating is also challenging.
A molecular virologist at the Florida Atlantic University School of Medicine, Massimo Caputi, has said, “I don’t know how the CDC built their algorithm, but human beings made these programs, and humans are fallible.” Here Massimo meant there are a number of human errors possible, and hence the goal should be to minimize the mistake possible so that people are prevented from the virus.
He finally added, “At the end of the day, you can predict as much as you want, but you need to look at the numbers you have in your hand.” for accuracy of the spread of the virus all over.
